First Cancer Protocol using Ivermectin, Mebendazole, and Fenbendazole Published

October 15, 2024

**UPDATE**

Since the paper was published, only more success has been had using repurposed drugs.

If you like getting information via video, go here for a 6 minute summary of the following paper.

https://isom.ca/article/targeting-the-mitochondrial-stem-cell-connection-in-cancer-treatment-a-hybrid-orthomolecular-protocol/

Targeting the Mitochondrial-Stem Cell Connection in Cancer Treatment: A Hybrid Orthomolectular Protocol

Ilyes Baghli1, William Makis2, Paul E. Marik3, Michael J. Gonzalez4,5,6, William B. Grant7, Ron Hunninghake8, Thomas E. Levy8, Homer Lim9, Richard Z. Cheng10, Igor Bondarenko11, Paul Bousquet12, Roberto Ortiz13, Mignonne Mary14, Dominic P. D’Agostino15, Pierrick Martinez16

Date of Publication: 19 September 2024

Abstract

The mitochondrial-stem cell connection (MSCC) theory suggests that cancer originates from chronic oxidative phosphorylation (OxPhos) insufficiency in stem cells. This OxPhos insufficiency leads to the formation of cancer stem cells (CSCs) and abnormal energy metabolism, ultimately resulting in malignancy. This concept integrates two well-established theories: the cancer stem cell theory and the metabolic theory. Drawing on insights from molecular biology, pharmacology, and clinical studies, this manuscript introduces a hybrid orthomolecular protocol targeting the MSCC. The protocol includes 7 therapeutic recommendations, consisting of orthomolecules, drugs, and additional therapies. The aim of this hybrid orthomolecular protocol is to achieve additive and synergistic effects to enhance OxPhos, inhibit the primary fuels of cancer cells (glucose and glutamine), target CSCs and metastasis. Thus, numerous experiments suggest that targeting MSCC could be a potential therapeutic approach for cancer treatment.  (See link for study)

_________________

http://

Fenben For CancerCase Presentations

Three patients with various genitourinary malignancies, who demonstrated complete response after receiving FBZ therapy, as a single or supplementary chemotherapeutic agent. In two patient scenarios, they had experienced progression of metastatic disease despite multiple lines of therapy prior to initiation of FBZ. No side effects from FBZ were reported.

As to cancer…every cancer registry in the world is up with new cases and documented rapid progression of disease aptly termed “turbo cancer.” Cases are up by 2.5X in New York state Medicaid vs. a 2017-2019 baseline, and The American Cancer Society states that this year the number of newly diagnosed cases of cancer will surpass  the 2 million mark for the first time ever.

The trendline went up with the rollout of genetic COVID-19 injections.

And it’s not like the FDA didn’t know.  The Moderna patent explains that when a foreign DNA sequence integrates with a host organism’s genome, it could lead to the activation of oncogenes, mutated genes that have the potential to cause cancer, or the inhibition of tumor suppression genes.  Researchers in the U.S. and Canada recently found DNA fragments in COVID-19 mRNA shots.

Go here for a review of a study that shows repeated injections of mRNA COVID-19 injections are taking down immune surveillance for nascent malignant cells while at the same time inducing autoimmunity.  

How was this allowed to happen?

Manufacturers skipped preclinical oncogenicity studies.

The COVID shots are highly contaminated with plasmids, SV40 sequences that have been linked to cancer, metals, PEG, nanotechnology, lipid nanoparticles, black particles, white floating matter, impurities from human fetal cell lines, hexagonal crystalline structures, parasites and eggs, and a hydra-like moving, self aware organisms.

But, according to the CDC, more than 240 billion dollars will be spent on cancer care in the United States on a yearly basis by 2030.  Just think about that.  That is close to a quarter of a trillion dollars going into the pockets of certain people and organizations.

Go here to download for FREE Dr. Marik’s entire book: Cancer Care: The Role of Repurposed Drugs and Metabolic Interventions in Treating Cancer, as well as webinar slides, cancer care summary, FLCCC cancer study, and also watch numerous videos.  You know an expert is serious when they make their hard work available for all at no cost.

For more:

http://  Scroll to 7:30

Ivermectin for Cancer

Oct. 12, 2024

Listen to Dr. Kathleen Ruddy, surgeon, researcher, and author on how ivermectin not only works for COVID but has 20 years of research showing its potential for cancer.  She met a previously healthy patient who ran marathons with no family history of cancer, but who developed stage 4 prostate cancer after being forced to get two Pfizer shots to keep his government job.  Under another doctor he did 9 months of radiation and chemotherapy only to be told, there’s nothing more to be done, go home and prepare to die.  At this point Ruddy met him and suggested he try ivermectin as she knew it wouldn’t hurt him and might help.  He drove to Tennessee where he paid cash for it as it was an over-the-counter drug there.  A few months after taking it he had his PSA checked which went from in the hundreds to 1.3 which is considered normal.  Nine months later he’s out dancing 3 nights a week for four hours.  A scan showed 3 of the four bone masses are gone.  

Category:

Cancer, research, Treatment

Comments Off on First Cancer Protocol using Ivermectin, Mebendazole, and Fenbendazole Published